Germany Grants BioNTech, CureVac $745 Mln to Speed Up COVID-19 Vaccine Work Germany Grants BioNTech, CureVac $745 Mln to Speed Up COVID-19 Vaccine Work

Germany awarded $745 million in funding to biotech firms BioNTech and CureVac on Tuesday to speed up work on COVID-19 vaccines and expand German production capacity.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news